RYTHM (RYM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Jun, 2026Executive summary
A virtual special meeting is scheduled for August 10, 2026, to vote on a single proposal regarding the issuance of shares of Common Stock related to convertible notes, warrants, and shared services agreements in compliance with Nasdaq Listing Rule 5635.
Only shareholders of record as of June 26, 2026, are eligible to vote, with 2,179,128 shares of Common Stock outstanding as of that date.
The Board unanimously recommends voting in favor of the proposal, citing the need for capital and strategic alignment with Green Thumb Industries.
Voting matters and shareholder proposals
The sole item for vote is the approval of share issuance to holders of certain convertible promissory notes and warrants, and under shared services agreements, as required by Nasdaq rules.
Approval requires a majority of votes cast, with abstentions not affecting the outcome.
No other business will be transacted at the meeting per company bylaws.
Advance notice procedures for future shareholder proposals and director nominations are outlined for the 2027 annual meeting.
Board of directors and corporate governance
The Board is composed of directors, including Benjamin Kovler (Chairman and Interim CEO) and Armon Vakili, both affiliated with Green Thumb Industries.
If the proposal is approved, Green Thumb, through RSLGH, could control over 90% of voting power, potentially qualifying the company as a "controlled company" under Nasdaq rules and exempting it from certain board independence requirements.
Latest events from RYTHM
- Shareholders will vote on issuing shares that could give Green Thumb Industries over 90% control.RYM
Proxy filing9 Jul 2026 - All proposals passed as the company targets THC market growth with strong brands and zero debt.RYM
AGM 202616 Jun 2026 - Rising THC demand, regulatory shifts, and strong licensing revenue drive growth and market reach.RYM
Investor presentation16 Jun 2026 - Q1 2026 net income $19.9M, 78% margin, revenue $13.3M, Q2 outlook $22M, strong licensing growth.RYM
Q1 20265 May 2026 - Virtual meeting to elect directors, ratify auditor, and expand equity plan on June 16, 2026.RYM
Proxy filing27 Apr 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan; Green Thumb holds 50%.RYM
Proxy filing27 Apr 2026 - Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025